Putting Patients First
We offer resources to help patients and their loved ones navigate some of the complex challenges that follow the words, “You have cancer.”
We are advancing an innovative, high-value product portfolio for patients globally.
Passion with Purpose
We work to benefit patients wherever they live by uniting worldwide talent and resources with our vision.
November 22, 2022
BeiGene to Present Final PFS Results from ALPINE Trial Demonstrating Superior PFS for BRUKINSA® Versus IMBRUVICA® in Late-Breaking Oral Session at ASH 2022Read more
November 17, 2022
BeiGene Receives European Commission Approval for BRUKINSA® (zanubrutinib) for the Treatment of Adults with Chronic Lymphocytic Leukemia (CLL)Read more
November 15, 2022
BeiGene Launches Talk About It Program to Elevate the Importance of Addressing Mental Health during Cancer CareRead more
November 10, 2022